Key Benefits:
Decision of 3 September 1997 laying down rules for the training of pharmacists (Decision on training of qualifications in pharmacy)
We Beatrix, at the grace of God, Queen of the Netherlands, Princess of Orange-Nassau, etc. etc. etc.
On the proposal of Our Minister for Health, Welfare and Sport of 22 January 1997, CSZ/BenO-97657,
Having regard to Article 22 of the Act on appeals in individual health care ;
Having regard to the opinion of the Council for the professions in individual health care (opinion of 15 May 1996, B4/'96);
Hearing the Council of State (opinion of 28 April 1997, no.W13.97.0035);
Having regard to the further report by Our Minister for Health, Welfare and Sport of 27 August 1997, CSZ/BO 9713645,
Have found good and understand:
For the purpose of this Decision:
a. Act: the Law on the professions in individual health care ;
a. medicinal product: a medicine as intended in Article 1, first paragraph, point (b) of the Pharmaceutical Act ;
c. Medical device: medical device as intended in Article 1, first paragraph, point (a) of the Law on Medical Devices .
To be in the Article 3 The register of pharmacists to be registered is required by the possession of a university as referred to in Article 13 (1) of the Act. Chapter 7 of the Law on Higher Education and Scientific Research Certificate showing that the person concerned has taken the final examination to close a pharmacist's training Article 3 and 4 of this Decision.
1 The pharmacist training includes theoretical and practical education as well as an internship of at least 6 months in a public pharmacy or a hospital pharmacy.
2 The theoretical and practical education shall comprise at least the following subjects:
a. Biology;
b. Physics;
c. General, inorganic, organic and analytical chemistry, including the analysis of biological material;
d. Pharmaceutical chemistry, including pharmaceuticals analysis;
Biochemistry, including medical biochemistry;
f. anatomy, physiology, pathology and clinical chemistry;
g. medical terminology;
h. microbiology;
pharmacology, including pharmacokinetics, pharmacotherapy, and clinical pharmacology;
j. pharmaceutical technology and biopharmaceuticals;
k. Toxicology;
l. Pharmacognosia;
m. professional ethics;
n. computerization.
The training of pharmacist shall be arranged so that the person concerned:
a. Sufficient knowledge must be acquired:
1 °C. of medicinal products placed on the market and the substances used in their manufacture, and of the preparation of medicinal products in their pharmaceutical form;
2 °. of the physical, chemical, biological and microbiological control of medicinal products;
3 degrees of metabolism, the effects of medicinal products, the functioning of toxic substances and the use of medicinal products;
4 °. to be able to assess scientific data on medicinal products and to provide relevant information on the basis of such information;
5 °. of the legislation, where relevant for the conduct of the pharmaceutical profession;
6 °. of medical devices, to the extent relevant to the pharmaceutical professional practice;
7 °. of the structure and financing of health care;
8 °C. of the storage, storage and distribution of medicinal products;
9 °. of information and recording systems;
b. sufficient skill must be acquired in:
1 °. communicate and collaborate with other health care workers;
2. to provide information and advice on the use of medicinal products and medical devices to healthcare professionals and patients;
3 °. the field of practice as pharmacoinic
4 °. preparation of medicinal products in their pharmaceutical form.
This Decision shall enter into force on a date to be determined by Royal Decree.
This decision is referred to as: 'Pharmacist training'.
Burden and order that this Decision, together with the accompanying note of explanatory note to the State Sheet will be placed.
' s-Gravenhage, 3 September 1997
Beatrix
The Minister for Health, Welfare and Sport,
E. Borst-Eilers
Published the seventh October 1997The Minister of Justice,
W. Sorgdrager
